Clinical experience with sulthiame (Ospolot).
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D001925:Brain Damage, Chronic / Q000150:complications; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D008297:Male; D001523:Mental Disorders / Q000150:complications*; D008875:Middle Aged; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D013843:Thiazines
D000927:Anticonvulsants; D013843:Thiazines; D011324:Primidone; D010672:Phenytoin; D010634:Phenobarbital